Delayed exercise-induced functional and neurochemical partial restoration following MPTP

Neurotoxicity Research

Volumn 21, Issue 2, 2012, Pages 210-221

  Archer, Trevor ^a,b   Fredriksson, Anders ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LINNAEUS UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

DA; Delay; Exercise; l Dopa; Locomotion; MPTP; Rearing; Restoration; Total activity

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; LEVODOPA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; FUNCTIONAL STATUS; HYPOKINESIA; INTERMETHOD COMPARISON; KINESIOTHERAPY; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY DELAY; THERAPY EFFECT; TREADMILL EXERCISE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DOPAMINE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MPTP POISONING; PHYSICAL CONDITIONING, ANIMAL;

MUS;

EID: 84856429460     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-011-9261-z     Document Type: Article

References (59)

1. Ahmad AO, Park J-H, Stenho-Bittel L, Lau YS (2009) Effects of endurance exercise on ventral tegmental area in the chronic 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine and probenecid-treated mice. Neurosci Lett 450:102-105
2. Al-Jarrah M, Jamous M, Al Zailaey K, Bweir SO (2010) Endurance exercise training promotes angiogenesis in the brain of chronic/progressive mouse model of Parkinson's disease. NeuroRehabilitation 26:369-373
3. Ang ET, Tai YK, Lo SQ, Seet R, Soong TW (2010) Neurodegenerative diseases: exercising toward neurogenesis and neuroregeneration. Front Aging Res 2:1-8
4. Antzoulatos E, Jakowec MW, Petzinger GM, Wood RI (2010) Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease. Pharmacol Biochem Behav 95:466-472
5. Archer T (2011) Physical exercise alleviates debilities of normal aging and Alzheimer's disease. Acta Neurol Scand 123:221-238
6. Archer T, Fredriksson A (2003) An antihypokinesic action of α2-adrenoceptors upon MPTP-induced behavior deficits in mice. J Neural Transm 110:183-200 (Pubitemid 36216500)
7. Archer T, Fredriksson A (2010) Physical exercise attenuates MPTP-induced deficits in mice. Neurotox Res 18:313-327
8. Archer T, Fredriksson A, Jonsson G, Lewander T, Mohammed AK, Ross SB, Söderberg U (1986) Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat. Psychopharmacology 88:141-146 (Pubitemid 16165671)
9. T Archer A Fredriksson B Johansson 2011 Exercise alleviates Parkinsonism: clinical and laboratory evidence Acta Neurol Scand 123 2 73 84 10.1111/j.1600-1404.2010.01360.x 21108623 10.1111/j.1600-0404.2010.01360.x 1:STN:280:DC%2BC3M%2Fot1Kiuw%3D%3D Archer T, Fredriksson A, Johansson B (2011a) Exercise alleviates Parkinsonism: clinical and laboratory evidence. Acta Neurol Scand 123(2):73-84. doi: 10.1111/j.1600-1404.2010.01360.x
10. Archer T, Fredriksson A, Schütz E, Kostrzewa RM (2011b) Influence of physical exercise on neuroimmunological functioning and health: aging and stress. Neurotox Res 20:69-83
11. Balthazar CH, Leite LH, Rodrigues AG, Coimbra CC (2009) Performance-enhancing and thermoregulatory effects of intracerebroventriculr dopamine in running rats. Pharmacol Biochem Behav 93:465-469
12. Ben-Ari S, Ofek K, Barbash S, Meiri H, Kovalev E, Greenberg DS, Soreq H, Shoham S (2011) Similar cation channels mediate protection from cerebellar exitotoxicity by exercise and inheritance. J Cell Mol Med. doi: 10.1111/j.1582-4934.2011.01331.x
13. Björk J, Lindgren S, Hacksell U, Lewander T (1991) (S)-UH-301 antagonizes (R)-8-OH-DPAT-induced cardiovascular effects in the rat. Eur J Pharmacol 199:367-370
14. Bridgewater KJ, Sharpe MH (1996) Aerobic exercise and early Parkinson's disease. J Neurol Rehabil 10:233-241 (Pubitemid 127002993)
15. Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ (2003) Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem 85:299-305 (Pubitemid 36438326)
16. Deslandes A, Moraes H, Ferreira C, Veiga H, Silveira H, Mouta R, Pompeu FA, Coutinho ES, Lake J (2009) Exercise and mental health: many reasons to move. Neuropsychobiology 59:191-198
17. Döbrössy MD, Dunnett SB (2003) Motor training effects on recovery of function after striatal lesions and striatal grafts. Exp Neurol 184:274-284 (Pubitemid 37444037)
18. ® BIG study. Movem Dis 25:1902-1908
19. Filippin NT, Lobo da Costa PH, Mattioli R (2010) Effects of treadmill-walking training with additional body load on quality of life in subjects with Parkinson's disease. Rev Bras Fisioter 14:344-350
20. Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW (2004) Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res 77:378-390 (Pubitemid 38970982)
21. Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG (2006) The science and practice of LSVT/LOUD: neural plasticity approach to treating individuals with Parkinson's disease and other neurological disorders. Semin Speech Lang 27:283-299 (Pubitemid 44970749)
22. Fredriksson A, Archer T (1994) MPTP-induced behavioural and biochemical deficits: a parametric analysis. J Neural Transm Dis Dement Dect 7:123-132 (Pubitemid 24158184)
23. Fredriksson A, Archer T (2003) Effect of postnatal iron administration on MPTP-induced behavioural deficits and neurotoxicity: behavioural enhancement by l-dopa-MK-801 co-administration. Behav Brain Res 139:31-46 (Pubitemid 36298490)
24. Fredriksson A, Plaznik A, Sundström E, Jonsson G, Archer T (1990) MPTP-induced hypoactivity in mice: reversal by l-dopa. Pharmacol Toxicol 67:295-301 (Pubitemid 20358734)
25. Fredriksson A, Plaznik A, Sundström E, Archer T (1994) Effects D1 and D2 agonists on spontaneous motor activity in MPTP-treated mice. Pharmacol Toxicol 75:36-41 (Pubitemid 24205429)
26. Fredriksson A, Palomo T, Chase TN, Archer T (1999) Tolerance to a suprathreshold dose of l-dopa in MPTP mice: effects of glutamate antagonists. J Neural Transm 106:283-300 (Pubitemid 29196932)
27. Fredriksson A, Stigsdotter IM, Hurtig A, Ewalds-Kvist B, Archer T (2011) Running wheel activity restores MPTP-induced functional deficits. J Neural Transm 18:407-420
28. Gerecke KM, Jiao Y, Pani A, Pagala V, Smeyne RJ (2010) Exercise protects against MPTP-induced neurotoxicity in mice. Brain Res 1341:72-83
29. Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL (2008) The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Movem Dis 23:631-640
30. Gorton LM, Vuckovic MG, Vertelkina N, Petzinger GM, Jakowec MW, Wood RI (2010) Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse. Behav Brain Res 213:253-262
31. Hassett LM, Tate RL, Moseley AM, Gillett LE (2011) Injury severity, age and pre-injury exercise history predict adherence to a home-based exercise programme in adults with traumatic brain injury. Brain Inj 25:698-706
32. Itoh T, Imano M, Nishida S, Tsubaki M, Hashimoto S, Ito A, Satou T (2011) Exercise inhibits neuronal apoptosis and improves cerebral function following rat traumatic brain injury. J Neural Transm. PMID:21442353
33. Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Neurodegeneration 4:257-269
34. King LA, Horak FB (2009) Delaying mobility disability in people with Parkinson disease using a sensorimotor agility exercise program. Phys Ther 89:384-393
35. Kirk RE (1995) Experimental design: procedures for the behavioral sciences. Brooks/Cole, Belmont, CA
36. Kurz MJ, Pothakos K, Jamaluddon S, Scott-Pandorf M, Arellano C, Lau Y-S (2007) A chronic mouse model of Parkinson's disease has a reduced gait pattern certainty. Neurosci Lett 429:39-42 (Pubitemid 350116350)
37. Langston JW (1985) MPTP neurotoxicity: an overview and characterization of phases of toxicity. Life Sci 36:201-206 (Pubitemid 15193978)
38. Lau YS, Patki G, Das-Panja K, Le WD, Ahmad SO (2011) Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate degeneration. Eur J Neurosci 33:1264-1274
39. Liu Y, Yu H, Mohell N, Nordvall G, Lewander T, Hacksell U (1995) Derivatives of cis-2-amino-8-hydroxy-1-methyltetraline: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists. J Med Chem 38:150-160
40. Macias M, Nowicka D, Czupryn A, Sulejczak D, Skup M, Skangiel-Kramska J, Czarkowska-Bauch J (2009) Exercised-induced motor improvement after complete spinal cord transection and its relation to expression of brain-derived neurotrophic factor and presynaptic markers. BMC Neurosci 10:144
41. Müller T, Muhlack S (2011) Effect of exercise on reactivity and motor behavior in patients with Parkinson's disease. J Neurol NeuroSurg Psychiatr 81:747-753
42. Novikova L, Garris BL, Garris DR, Lau YS (2006) Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine/ probenecid model of Parkinson's disease. Neuroscience 140:67-76 (Pubitemid 43668437)
43. Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M (2010) BDNF function and intracellular signaling in neurons. Histol Histopathol 25:237-258
44. O'Dell SJ, Gross NB, Fricks AN, Casiano BD, Nguyen TB, Marshall JF (2007) Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection. Neuroscience 144:1141-1151 (Pubitemid 46014003)
45. Palmer SS, Mortimer JA, Webster DD, Bistevins R, Dickinson GL (1986) Exercise therapy for Parkinson's disease. Arch Phys Med Rehabil 67:741-745 (Pubitemid 16002528)
46. Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P, Turnquist P, Vuckovic M, Fisher BE, Togasaki DM, Jakowec MW (2007) Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci 27:52291-52300 (Pubitemid 46790176)
47. Pohl M, Rockstroh G, Ruckriem S, Mrass G, Mehrholz J (2003) Immediate effects of speed-dependent treadmill training on gait parameters in early Parkinson's disease. Arch Phys Med Rehabil 84:1760-1766 (Pubitemid 37509785)
48. Pothakos K, Kurz MJ, Lau YS (2009) Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration. BMC Neurosci 10:1-10
49. Reznichenko L, Kalfon L, Amit T, Youdim MB, Mandel SA (2010) Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced Parkinsonism. Neurodegener Dis 7(4):219-231
50. Schebeleski-Soares C, Occhi-Soares RC, Franzoi-Moraes SM, de Oliveira Dalalio MM, Almeida FN, de Ornelas Toledo MJ, de Araujo SM (2009) Preinfection aerobic treadmill training improves resistance against Trypanosoma cruzi infection in mice. Appl Physiol Nutr Metab 34:659-665
51. Sundström E, Fredriksson A, Archer T (1990) Chronic neurochemical and behavioural changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease. Brain Res 528:181-188 (Pubitemid 20318194)
52. Tillerson JL, Cohen AD, Philpower J, Miller GW, Zigmond MJ, Schallert T (2001) Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 21:4427-4435 (Pubitemid 32538569)
53. Tillerson JL, Caudle WM, Reveron ME, Miller GW (2002) Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Exp Neurol 178:80-90 (Pubitemid 35425611)
54. Tillerson JL, Caudle WM, Reveron ME, Miller GW (2003) Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience 119:899-911 (Pubitemid 36694814)
55. Vargas-Perez H, Borelli E, Diaz J-L (2004) Wheel running use in dopamine D2L receptor knockout mice. Neurosci Lett 366:172-175 (Pubitemid 38970150)
56. Werme M, Thoren P, Olson L, Brene S (2000) Running and cocaine both upregulate dynorphin mRNA in medial caudate putamen. Eur J Neurosci 12:2967-2974
57. Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A, Chen H (2010) Physical activities and future risk of Parkinson disease. Neurology 75:341-348
58. Yoon MC, Shin MS, Kim TS, Kim BK, Ko IG, Sung YH, Kim SE, Lee HH, Kim YP, Kim CJ (2007) Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats. Neurosci Lett 423:12-17 (Pubitemid 47176783)
59. Zigmond MJ, Cameron JL, Leak RK, Mirnics K, Russell VA, Smeyne RJ, Smith AD (2009) Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. Parkinson Rel Disord 1553:S42-S45